Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference
Provided By GlobeNewswire
Last update: Jan 2, 2025
REDWOOD CITY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that the company will be participating in the upcoming J.P. Morgan 43rd Annual Healthcare Conference in San Francisco, CA.
Read more at globenewswire.comNASDAQ:SEER (7/25/2025, 8:24:45 PM)
2.2
+0.02 (+0.92%)
Find more stocks in the Stock Screener
